+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Resynchronization Therapy (CRT) Devices: Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • November 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139738
Description Jump to:

Quick Summary:

In an age where health technology is rapidly advancing, it is crucial to stay informed about key industry shifts. Our exclusive market research report on the Global Cardiac Resynchronization Therapy (CRT) Devices Market, which is projected to grow substantially by 2030, serves as the guide you need to navigate the complexities of this dynamic landscape with confidence and insight.

Covering diverse geographical regions including the U.S, China, Japan, Canada, and Germany, this report offers an in-depth examination of major competitors like Abbott Laboratories and Boston Scientific Corporation, along with 42 other leading organizations in the field. Additionally, we offer premium features such as online interactive peer-to-peer collaborative bespoke updates, access to digital archives, and complimentary updates for one year, ensuring that you're always up to date with the latest industry developments. With our report, empower your business with the knowledge to make informed decisions and propel your success in the Cardiac Resynchronization Therapy Devices Market.

Global Cardiac Resynchronization Therapy (CRT) Devices Market to Reach $9.8 Billion by 2030

The global market for Cardiac Resynchronization Therapy (CRT) Devices estimated at US$5.4 Billion in the year 2022, is projected to reach a revised size of US$9.8 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2022-2030. CRT-Defibrillator (CRT-D), one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the CRT-Pacemaker (CRT-P) segment is readjusted to a revised 8.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 7.3% CAGR

The Cardiac Resynchronization Therapy (CRT) Devices market in the U.S. is estimated at US$1.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic PLC

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Cardiac Resynchronization Therapy (CRT) Devices

What is the estimated value of the Global Market for Cardiac Resynchronization Therapy (CRT) Devices?

The Global Market for Cardiac Resynchronization Therapy (CRT) Devices was estimated to be valued at $5.4 Billion in 2022.

What is the growth rate of the Global Market for Cardiac Resynchronization Therapy (CRT) Devices?

The growth rate of the Global Market for Cardiac Resynchronization Therapy (CRT) Devices is 7.7%, with an estimated value of $9.8 Billion by 2030.

What is the forecasted size of the Global Market for Cardiac Resynchronization Therapy (CRT) Devices?

The Global Market for Cardiac Resynchronization Therapy (CRT) Devices is estimated to be worth $9.8 Billion by 2030.

Who are the key companies in the Global Market for Cardiac Resynchronization Therapy (CRT) Devices?

Key companies in the Global Market for Cardiac Resynchronization Therapy (CRT) Devices include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova PLC and Medtronic PLC.
Report AttributeDetails
No. of Pages194
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 5.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.8 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cardiac Resynchronization Therapy (CRT) Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for CRT-Defibrillator (CRT-D) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for CRT-Pacemaker (CRT-P) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Cardiac Resynchronization Therapy (CRT) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 11: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 13: World 16-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 18: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 19: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 20: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 22: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 24: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 25: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 26: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
JAPAN
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 29: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 32: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
CHINA
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 35: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 38: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
EUROPE
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 41: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 42: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
FRANCE
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 50: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 53: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
GERMANY
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 56: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 59: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 61: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
ITALY
  • Table 62: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 64: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 65: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 67: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 68: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 70: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 71: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 72: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 73: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 76: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 78: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 79: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 82: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 84: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 85: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 86: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 88: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2023 & 2030
  • Table 89: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 90: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 91: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic PLC

Related Topics

Related Reports

Cardiac Resynchronization Therapy Market Size, Share & Trends Analysis Report By Product (CRT-Defibrillator, CRT-Pacemaker), By End-use (Hospitals, Cardiac Centers, Others), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cardiac Resynchronization Therapy Market Size, Share & Trends Analysis Report By Product (CRT-Defibrillator, CRT-Pacemaker), By End-use (Hospitals, Cardiac Centers, Others), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Cardiovascular Devices Global Market Report 2023 - Product Image

Cardiovascular Devices Global Market Report 2023

  • Report
  • 400 Pages
  • Global
From
Defibrillator: Global Market Outlook - Product Image

Defibrillator: Global Market Outlook

  • Report
  • 78 Pages
  • Global
From
Global Cardiac Resynchronization Therapy Devices Market by Product (Cardiac Resynchronization Therapy Defibrillators, Cardiac Resynchronization Therapy Pacemakers), End-User (Ambulatory Surgery Centers, Hospitals & Cardiac Centers) - Forecast 2023-2030 - Product Image

Global Cardiac Resynchronization Therapy Devices Market by Product (Cardiac Resynchronization Therapy Defibrillators, Cardiac Resynchronization Therapy Pacemakers), End-User (Ambulatory Surgery Centers, Hospitals & Cardiac Centers) - Forecast 2023-2030

  • Report
  • 199 Pages
  • Global
From
Global Pacemaker Market, By Type (Implantable v/s External), By Technology (Dual Chamber, Single Chamber, Biventricular Chamber), By Product Type, By Applications, By End User, By Region, Competition, Forecast & Opportunities, 2017-2027 - Product Image

Global Pacemaker Market, By Type (Implantable v/s External), By Technology (Dual Chamber, Single Chamber, Biventricular Chamber), By Product Type, By Applications, By End User, By Region, Competition, Forecast & Opportunities, 2017-2027

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.